# OnCo record tim-maughan (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/tim-maughan/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "tim-maughan" ;
  schema:name "Tim Maughan"@en ;
  schema:description "The oncologist who led COIN, which showed that adding cetuximab to first-line chemotherapy did not extend life even in RAS wild-type bowel cancer, and who ran the UK's molecularly stratified platform trial."@en ;
  schema:url <https://onco.cc/people/tim-maughan/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://www.oncology.ox.ac.uk/team/tim-maughan> ;
  onco:tag "colorectal", "trialist", "uk" ;
  schema:jobTitle "Emeritus Professor of Clinical Oncology, University of Oxford" ;
  onco:related <https://onco.cc/people/matt-seymour/>, <https://onco.cc/people/rachel-kerr/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:targets <https://onco.cc/targets/kras/>, <https://onco.cc/targets/braf/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/capecitabine/> ;
  onco:institutions <https://onco.cc/institutions/oxford-cancer/>, <https://onco.cc/institutions/velindre-cardiff/> ;
  onco:trials <https://onco.cc/trials/coin/>, <https://onco.cc/trials/focus4/> ;
  schema:affiliation <https://onco.cc/institutions/oxford-cancer/> .